P947: TREATMENT PATTERNS AND OUTCOMES OF RE-INDUCTION THERAPIES PRIOR TO STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED IN CLINICAL PRACTICE IN GERMANY

• Sandra Sauer,
• Monika Engelhardt,
• Karolin Trautmann-Grill,
• Christoph Kimmich,
• Mathias Hänel,
• Martin Schmidt-Hieber,
• Hans Salwender,
• Carmen Flossmann,
• Hiltrud Heckmann,
• Franziska Ertel,
• Andrea Friederich,
• Sachin Patel,
• Sabine Piesch,
• Barbara Thun,
• Marc S. Raab

Affiliations

Sandra Sauer

1 University Hospital Heidelberg, Department of Hematology, Oncology and Rheumatology, Heidelberg, Germany

Monika Engelhardt

2 Faculty of Freiburg, Medical Department, Hematology, Oncology & Stem Cell Transplantation, Freiburg, Germany

Karolin Trautmann-Grill

3 University Hospital Carl Gustav Carus at the TU Dresden, Medical Clinic I, Dresden, Germany

Christoph Kimmich

4 University Clinic Oldenburg, Department of Oncology and Hematology, Oldenburg, Germany

Mathias Hänel

5 Chemnitz Hospital, Department of Internal Medicine III, Chemnitz, Germany

Martin Schmidt-Hieber

6 Carl-Thiem-Clinic, Cottbus, Germany

Hans Salwender

7 AK Altona and AK St Georg, Asklepios Tumorzentrum Hamburg, Hamburg, Germany

Carmen Flossmann

8 Amgen GmbH, Munich, Germany

Hiltrud Heckmann

8 Amgen GmbH, Munich, Germany

Franziska Ertel

8 Amgen GmbH, Munich, Germany

Andrea Friederich

8 Amgen GmbH, Munich, Germany

Sachin Patel

9 Amgen Ltd, Uxbridge, United Kingdom

Sabine Piesch

10 IQVIA Commercial GmbH & Co. OHG, Munich, Germany

Barbara Thun

10 IQVIA Commercial GmbH & Co. OHG, Munich, Germany

Marc S. Raab

1 University Hospital Heidelberg, Department of Hematology, Oncology and Rheumatology, Heidelberg, Germany